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ABSTRACT This study evaluated the effect of the systemic use of sodium alendronate in rats
in vivo. Forty-five Wistar rats aged 36 to 42 days and weighing 200 to 230 g were randomly
assigned to a control group (n 5 20), which received distilled water, and an experimental group (n
5 25), which received 2 weekly doses of 1 mg/kg of chemically pure sodium alendronate. The ani-
mals were killed after 60 days of treatment. The tibias were removed for analysis of bone mineral
density by dual-energy X-ray absorptiometry (DXA). Then, the maxillary incisors were extracted
for analysis of the mineralized dental tissues using fluorescence spectroscopy (FS), scanning elec-
tron microscopy (SEM), bright field microscopy (BFM), and cross-sectional microhardness (CSMH)
testing. DXA and CSMH data were subjected to statistical analysis by Kruskal-Wallis test (5% sig-
nificance level). The experimental group presented higher bone mineral density than the control
group by DXA. FS analysis revealed presence of alendronate in the mineralized dental tissues of
the specimens of the experimental group. Significant morphological differences were not found by
SEM and BFM. Enamel and dentin (100 and 300 lm from the dentinoenamel junction) CSMH data
did not show significant difference between the control and experimental groups. Based on the
obtained results, we conclude that while alendronate increased the bone mineral density and was
incorporated into the mineralized dental tissues it did not cause significant alterations in the mor-
phology and microhardness of rat incisor enamel and dentin. Microsc. Res. Tech. 75:1265–1271,
2012. VC 2012 Wiley Periodicals, Inc.
INTRODUCTION
Bisphosphonates are a class of analogs of pyrophos-
phate with high affinity to hydroxyapatite (Brada-
schia-Correa et al., 2007), which act on bone metabo-
lism and are widely used in the prevention and treat-
ment of osteopenic and osteoporotic conditions, such as
osteoporosis, Paget’s disease, and hypercalcemia
related to malignancy (Russell et al., 2007, 2008; Vasi-
karan, 2001).
Sodium alendronate, a recently developed aminobi-
sphosphonate, is a compound that strongly binds to the
hydroxyapatite of the bone, preferentially to crystals at
the sites of active resorption, and inhibits the formation,
aggregation, and dissolution of the crystals (Russell
et al., 2008). It also causes toxic effects on osteoclasts,
resulting in disorders in their cytoskeleton and intracel-
lular signaling, inhibition of adhesion mechanisms,
structural changes in the ruffle border, and decrease of
their acid production (Bradaschia-Correa et al., 2007).
As a result, osteoclasts may become latent or inactive
and undergo apoptosis (Vasikaran, 2001), inhibiting
osteoclastic bone resorption (Fleisch, 2007). The affinity
of sodium alendronate for calcium phosphate and its
strong binding to hydroxyapatite promotes a rapid incor-
poration of this compound to the tissues. Its half-life in
serum is short, a few hours or less, whereas the half-life
in the bone may be several years depending on the rate
of bone remodeling (Srivastava and Alon, 2003).
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This drug is indicated in the therapy of several pedi-
atric bone disorders (Srivastava and Alon, 2003), such
as childhood osteoporosis (Bachrach and Ward, 2009),
osteogenesis imperfect (Ward et al., 2011), vitamin D
intoxication (Orbak et al., 2006), primary hyperpara-
thyroidism (Mallet, 2008), hypercalcemia and hyper-
calciuria (Freundlich and Alon, 2008). It is possible
that the alendronate administration to children or ado-
lescents, in whom odontogenesis and/or tooth eruption
are still taking place, might induce structural altera-
tions in the teeth or even the failure of tooth eruption
(Bradaschia-Correa et al., 2007).
Although the mechanism of action of sodium alendro-
nate has been extensively investigated in bone (Azaras
and Rezvani, 2010; Diab et al., 2009; Enjuanes et al.,
2010; Ward et al., 2011), little is known about its effects
in the formation of mineralized dental tissues, limited to
enamel (Espı´rito Santo et al., 2010; Massa et al., 2006).
To the best of our knowledge there are no studies inves-
tigating the effects of sodium alendronate on dentin.
We hypothesize that sodium alendronate could be
incorporated into enamel/dentin, causing changes in
these tissues that could be associated with higher risk
to caries development. In this in vivo study we systemi-
cally administered sodium alendronate to rats and
examined the alteration of bone mineral density of the
proximal tibial metaphysis by dual-energy X-ray
absorptiometry (DXA) to confirm that the drug was bio-
available and absorbed in the bones. In addition, we
evaluated: (1) incorporation of the drug to the mineral-
ized dental tissues, using fluorescence spectroscopy
(FS); (2) structural and mechanical alterations in these
tissues, using scanning electron microscopy (SEM),
bright field microscopy (BFM), and cross-sectional
microhardness (CSMH) testing.
MATERIAL ANDMETHODS
Forty-five 36- to 42-day-old male Wistar rats (Rattus
norvegicus albinus) (200–230 g) were used, after ap-
proval of the study by the Institutional Ethics Commit-
tee for Animal Care and Research Use (Protocol
10.1.468.53.5). The animals were housed in cages with
natural lightening and mean temperature of 24 6 0.58C,
and were fed standard rat chow and water ad libitum.
The animals were randomly assigned to a control
group (n 5 20), which received distilled water, and an
experimental group (n 5 25), which received chemically
pure sodium alendronate (alendronate monosodium tri-
hydrate; Galena Quı´mica e Farmaceˆutica Ltda., SP,
Brazil) at a dose of 1 mg/kg body weight diluted in dis-
tilled water. As the metabolic rate is twice as faster in
rats than in humans (Keidel, 1971), the drug was
administrated twice a week (Tuesdays and Fridays)
always in the same period of the day to reach a dose
compatible to the one given to human patients (1 mg/kg
body weight once a week). A volume of 0.3 mL was
administered at each day by gavage. A 3-cm long sili-
cone gastrointestinal tube (#6 Levin tube) coupled to a
disposable 1 mL syringe was used to inject the solution
directly into the gastrointestinal tract. The control ani-
mals received only distilled water by the same route of
administration. The animals were weighed every week
in an electronic precision scale (Model 3400, Toledo do
Brasil Ind. de Balanc¸as Ltda., Toledo, PR, Brazil) in
order to adjust the dose of the sodium alendronate solu-
tion according to the body weight of the animals.
Rats were killed after 60 days of treatment with a
lethal injection of a mixture of ketamine hydrochloride
(Ketamina Agener1, Unia˜o Quı´mica Farmaeˆutica
Nacional, Embu-Guac¸u, SP, Brazil; 300 mg/mL) and
xylazine hydrochloride (Dopaser1; Caleir S.A., Barce-
lona, Spain; 30 mg/mL). The tibias were removed and
the maxillary incisors were extracted, which had been
previously submitted to the randomization to be allo-
cated to the further different analyses (Table 1), using
the SAS (Statistical Analysis System) software for Win-
dows version 9.1.3 (SAS Institute Inc., Cary, NC).
DXA Analysis
Sixteen tibias of the experimental group and 10 of
the control group were surgically removed and the
proximal tibial metaphysis was analyzed with a dual-
energy X-ray densitometer (Dual Lunar PIXImus; PIX-
Imus Corp. Headquarters, Madison, WI) to record the
bone mineral density in g/cm2. Data were analyzed
using the Lunar PIXImus software, version 2.2 (Lunar
PIXImus Corp. Headquarters).
FS Analysis
A calibration curve was first constructed using 10, 20,
30, and 40 mL of a sodium alendronate solution at 0.086
mg/mL, which was subjected to the derivatization reac-
tion (De Marco et al., 1989) in order to emit fluores-
cence, since sodium alendronate does not have chromo-
phoric properties. Then, three maxillary incisors of each
group were triturated in a grail and agate pistil to
increase the contact surface with the solution. The study
was performed in triplicate, totalizing nine teeth per
group. The resulting tooth fragments were placed in
beakers containing 5 mL of sodium borate under agita-
tion during 24 h to allow for extraction of the sodium
alendronate that could have been incorporated to the
dental tissues during the mineralization phase. Next,
the remaining solution of each sample was collected and
transferred to a flat-bottom glass balloon for the deriva-
tization reaction. After addition of 5 mL of sodium
citrate and 4 mL of 9-fluorenylmethyl chloroformate
(FMOC), the solution was agitated for 30 s and, after 30
min had elapsed for the reaction to occur, 25 mL of
dichloromethane were added to extract the excess of
FMOC reagent. The balloon with the solution was then
agitated in an automatic agitator for 30 s, left rest for 5
min and, then centrifuged at 1,000 rpm for 5 min to
eliminate the excess of reagent. The upper portion of the
aqueous phase of each sample was transferred to
TABLE 1. Analyses employed for evaluation of the tibias and
maxillary incisors and number of specimens used in each analysis
Specimen
Type of
analysis
No. specimens
Experimental group Control group
Tibia DXA 16 10
Maxillary incisor FS 9 9
SEM 10 10
BFM 3 3
CSMH 20 12
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another flask for the reading. The sodium alendronate/
FMOC derivative formed after reaction has lumines-
cence upon excitation at 266 nm, with emission spectra
at 315 nm (De Marco et al., 1989). The excitation and
emission spectra of the sodium alendronate/FMOC de-
rivative were analyzed with a spectrofluorometer (Shi-
madzu RF-5301PC Series; Shimadzu, Kyoto, Japan)
equipped with a 150 W ozone-free xenon arc lamp. The
results were evaluated by analysis of the obtained spec-
tra, determining the percentage of sodium alendronate
incorporated to the teeth (amount of sodium alendro-
nate per weight of each tooth).
SEM Analysis
In preparation for the SEM analysis, 10 maxillary
incisors of both groups were cleaned and immersed in
modified Karnovsky solution (8% glutaraldehyde, 12%
paraformaldehyde, and 0.2 M sodium cacodylate; pH
7.2–7.4) for fixation during 5 days. After this period,
they were washed in 0.1 M sodium cacodylate buffer,
air-dried, mounted on metallic stubs, and sputter-
coated with gold (Emitech K650 Sputter Coater; Lon-
don, England) until obtaining an approximately 200-
lm thick coating, and were examined with a scanning
electron microscope (DSM 940A, Zeiss, Oberkochen,
Germany). Five maxillary incisors of each group were
used to analyze the structure of the external enamel
surface at 503, 5003, and 1,5003 magnifications, hav-
ing the incisal border as the reference point for record-
ing the SEM images. The other five maxillary incisors
of each group had the mesial surface ground until
exposing dentin to analyze enamel and dentin struc-
ture in depth at 5003 and 2,0003 magnifications, hav-
ing the DEJ as the reference point for analysis. The
SEM micrographs were examined for the topographical
and structural aspects of enamel and dentin.
BFM Analysis
Three maxillary incisors of each group had the mesial
and distal surfaces of the teeth ground with 400-, 600-,
1,200-, and 4,000-grit silicon carbide paper (Saint-
Gobain Abrasivos Ltda.) until obtaining specimens with
thickness of 100 lm in the central portion, as measured
with a digital caliper (Vonder Instrumentos de Medic¸a˜o,
Sa˜o Paulo, SP, Brazil). The specimens were maintained
in 0.02% sodium azide solution during preparation, and
then washed with distilled water and mounted in micro-
scopic slides for qualitative analysis by BFM using an
Axioskop 40 microscope (Carl Zeiss, Germany). The ana-
lyzed parameters were enamel and dentin structure
and iron deposition on enamel surface.
CSMH Analysis
Thirty-two maxillary incisors (20 from the experi-
mental group and 12 from the control group) were used
for this analysis. For preparation of specimens, the
teeth were embedded in chemically activated polyester
resin with the mesial surface exposed (Mioflex1; Mio-
flex General Tintas and Vernizes Ltda, Jandira, SP,
Brazil). After resin polymerization, the specimens were
ground with 600- and 1,200-grit silicon carbide paper
(Saint-Gobain Abrasivos Ltda., Jundiaı´, SP, Brazil) in
a water-cooled polishing machine (Struers A/S, Copen-
hagen, Denmark) to expose a flat dentin surface. The
specimens were polished with 0.3 lm alumina slurry
(Alpha and Gamma Micropolish, Buehler, Lake Bluff,
IL) on a felt polishing wheel (Buhler1, Germany), and
then rinsed with deionized water, ultrasonically
cleaned with deionized water for 10 min and stored at
378C in relative humidity until the moment of test,
within 7 days.
Specimens were tested for CSMH using a Shimadzu
HMV-2 hardness meter (Shimadzu Corp., Kyoto, Ja-
pan) with a Knoop indenter under a load of 25 g in
enamel and 10 g in dentin (Faraoni-Romano et al.,
2008) for 10 s in each substrate. Knoop microhardness
(KHN) was measured using the Newage C.A.M.S soft-
ware (Computer Assisted Measurement System; New-
age Testing Instruments, Inc., Southampton, PA). In
enamel, five indentations spaced 200 lm from each
other were made in each specimen equidistantly
between the dentinoenamel junction (DEJ) and the
external surface of the tooth, based on a previous anal-
ysis of the enamel CSMH in rat teeth (Vieira et al.,
2005). The average of the five CSMH values was calcu-
lated. In dentin, five indentations spaced 200 lm from
each other were made at 100 lm and 300 lm from the
DEJ. The average of the five CSMH values was calcu-
lated for each depth.
Statistical Analysis
DXA and CSMH data were analyzed statistically by
the Kruskal-Wallis test at 5% significance level using
the SAS software.
RESULTS
The animals in both groups had a similar gradual
weight gain during the experiment (data not shown).
This indicates that the administration of sodium alen-
dronate did not affect growth.
DXA Analysis
Figure 1A presents the bone mineral density values
of the proximal metaphysis of the tibia obtained by
DXA (g/cm2) in both groups at day 60. The group
treated with sodium alendronate had significantly
higher bone mineral density than the control group (P
< 0.05), which confirms that the alendronate adminis-
tration protocol was adequate, as treatment resulted in
significant increase in bone mineral density.
FS Analysis
The emission spectra of the control and experimental
groups are shown in Figure 2. The experimental group
spectrum presented an emission band with peak at 315
nm which, compared with the calibration curve, sug-
gesting that sodium alendronate was incorporated to
the dental tissues. This was not observed in the emis-
sion spectrum of the control group (distilled water).
From the analysis of the calibration curve, it was possi-
ble to determine the amount de sodium alendronate
incorporated to the mineralized tissues of each tooth
(0.0018%).
The presence of alendronate in our tooth samples
has also been independently confirmed by qualitative
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Fourier transform infrared spectroscopy (data not
shown).
SEM Analysis
SEM micrographs of the external enamel and inter-
nal enamel and dentin of the rat incisors in the experi-
mental and control groups are presented in Figures
3A–3C and Figures 3E–3G, respectively. In both
groups, the external surface enamel was homogeneous,
with regular contour and no structural alterations. In-
ternal examination of enamel and dentin did not reveal
differences between the groups, and the mineralized
dental tissues exhibited normal characteristics.
BFM Analysis
Dentin and enamel exhibited normal appearance.
There were no alterations in iron pigmentation on
enamel surface after administration of sodium alendro-
nate, compared with the control group. Comparison of
the images obtained in the experimental (Fig. 3D) and
control groups (Fig. 3H) did not reveal structural alter-
ations or evidence of increased retention of organic
components in the mature enamel or dentin. Other
morphological changes that are common when dentin
has mineralization problems, such as increased areas
of interglobular dentin, were not detected. Changes in
the mineralization pattern, such as lines of increased
or decreased mineral content, were not observed either.
The morphological analysis showed three histological
layers on enamel (outer, central, and inner). As
described before, the central layer had the highest min-
eral content, followed by the outer and inner layers
(Saiani et al., 2009).
Polarized light microscopy has also been carried out
(data and images not shown), and this technique as
well did not pointed out any morphological/structural
alterations same as SEM and BFM.
CSMH Analysis
Figures 1B–1D present the CSMH values (KHN) of
enamel (between the DEJ and the external tooth sur-
Fig. 2. Emission spectra (kex 5 266 nm) of the solutions obtained
from samples of the control and experimental groups, showing the
incorporation of alendronate into the mineralized dental structure.
Fig. 1. Statistical box plots expressing minimum values, first
quartiles, medians, third quartiles, and maximum values of DXA and
CSMH data. Bone mineral density values of proximal tibial metaphy-
sis obtained by DXA (g/cm2) (A) and CSMH (KHN) of enamel (B), den-
tin at 100 lm from the dentinoenamel junction (C), and dentin at 300
lm from the dentinoenamel junction (D) in the experimental (admin-
istration of sodium alendronate) and control (administration of dis-
tilled water) groups. *Statistically significant difference.
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Fig. 3. Experimental group (administration of sodium alendro-
nate) (A–D) and control group (administration of distilled water) (E–
H). SEM micrographs showing homogeneous buccal external enamel
surface, with regular contour and no structural alterations (A and E).
SEM micrographs of internal regions of enamel (B and F) and dentin
(C and G) showing normal morphology. Cross-section of enamel and
dentin by bright field microscopy (D and H) in which no structural
alterations is displayed.
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face) and dentin (100 and 300 lm from the DEJ) in the
experimental and control groups. No statistically sig-
nificant difference (P > 0.05) was found between the
groups either in enamel or in dentin (both depths),
demonstrating that the administration of sodium alen-
dronate did not alter the enamel and dentin (at 100
and 300 lm from the DEJ) CSMH compared with the
control group.
DISCUSSION
Odontogenesis involves a series of complex interac-
tions among different cell types and between cells and
the extracellular matrix. These interactions result in
the differentiation of odontoblasts and ameloblasts,
which form dentin and enamel, respectively (Thesleff
et al., 1995).
A great variety of conditions and drugs may disturb
the normal formation and mineralization of teeth
(Small and Murray, 1978). For instance, the effects of
etidronate (HEBP), a nonaminobisphosphonate, on col-
lagen fibrillogenesis, matrix synthesis, and mineraliza-
tion of dentin have been reported (Beertsen et al.,
1985; Larsson, 1974; Ogawa et al., 1989; Sakai et al.,
1999; Takano et al., 1998). HEBP has also been shown
to affect enamel mineralization (Espı´rito Santo et al.,
2010; Fouda et al., 1989, 1991, 1992; Weile et al., 1990,
1993), ameloblast morphology (Fejerskov et al., 1990;
Josephsen et al., 1990), and ameloblast functions,
including effects on protein synthesis and secretion
(Fuangtharnthip et al., 2000; Yamada et al., 2000),
with development of hypoplasia and formation of suba-
meloblastic cysts (Fejerskov et al, 1990; Fouda et al.,
1989, 1991, 1992; Simmelink, 1987).
Sodium alendronate, on the other hand, belongs to
the group of aminobisphosphonates and it has been
widely prescribed for patients with bone disorders
(Inoue et al., 2008; Kawate et al., 2010; Orbak et al.,
2006). In the present study, the DXA analysis
revealed an increase in the bone mineral density of
the proximal tibial metaphysis after exposure to
sodium alendronate, which confirms previous reports
(Freundlich and Alon, 2008; Inoue et al., 2008;
Kawate et al., 2010). Despite being widely used, few
studies evaluated the effect of sodium alendronate in
dental hard tissue formation in vivo, and those avail-
able are limited to enamel (Espı´rito Santo et al., 2010;
Massa et al., 2006).
In the present study, quantitative chemical analy-
sis by FS revealed the presence of sodium alendro-
nate in the mineralized dental tissues of rat teeth
(0.0018% per tooth) after systemic administration of
this drug, which indicates that it is bioavailable in
the organism during formation of the teeth. To the
best of our knowledge, this is the first study reporting
such observation. Unlike other mineralized tissues,
in which the mineral is deposited toward the direc-
tion the organic matrix, enamel loses most of the pro-
teins and water present in its organic matrix during
amelogenesis, becoming the most mineralized tissue
in mammals. For this reason enamel does not nor-
mally undergo remodeling once its formation is com-
pleted and incorporated substances or structural
alterations become permanent (Gerlach et al., 2002).
Microhardness values are usually employed to evalu-
ate the structural quality of enamel (Gerlach et al.,
2002) and dentin. In the present study, it was not pos-
sible to observe significant differences in the CSMH
of enamel (between the DEJ and the external tooth
surface) or dentin (100 and 300 lm from the DEJ)
comparing the control and alendronate-treated
groups. Neither were observed any structural altera-
tions in the mineralized tissues by SEM after expo-
sure to systemic sodium alendronate.
Finally, the analysis of the enamel and dentin by
BFM showed no morphological alterations in the extrac-
ellular matrix. A recent study (Espı´rito Santo et al.,
2010) evaluated the birefringence of enamel organic
extracellular matrix during the secretory stage and the
mechanical properties of the enamel of maxillary inci-
sors of rats treated with subcutaneously injected sodium
alendronate (30 lg/kg/day). The morphological altera-
tions in the extracellular matrix reported by those
authors were not observed in the present study probably
because they evaluated immature enamel while we
evaluated mature enamel in addition to using different
alendronate dose and route of drug administration. In
the present study, a dose of about 286 lg/kg/day was
administered to the rats, which is almost 10 times
higher as compared to the 30 lg/kg/day of the cited
study; however, different routes of administration were
used in these studies. As mentioned before, the alendro-
nate dose used in the present study was calculated to
reach a dose compatible to the one given to human
patients. Additionally, administration by gavage aims at
reproducing in a more reliable form the route of admin-
istration used in patients (oral route).
The amount of alendronate found in this study was
0.0018% per tooth, after systemic administration of
this drug, and probably was not sufficient to cause
significant alterations according to the tested param-
eters. However, it is a valuable finding that confirms
the strong affinity of alendronate for hydroxyapatite
and its rapid incorporation to the matrix of mineral-
ized tissues, including teeth, during the mineraliza-
tion phase. The literature has shown that, similarly,
other elements are incorporated to the dental tissues
and might cause several effects. An excellent exam-
ple is fluoride, which is known to reduce the solubil-
ity of dental substrate to acid attacks from cariogenic
challenge, playing a key role in the prevention and
control of dental caries (Leite et al., 2011). Likewise,
lead is incorporated to calcified dental tissues, which
allows assessing subclinical past systemic exposure
to this ion (Sawan et al., 2010). Thereby, further
studies are needed to investigate what effects can
appear after alendronate incorporation to the dental
tissues, for example, whether it may alter their re-
sistance to acid demineralization, making the tooth
more or less susceptible to caries disease or erosive
processes.
Based on the obtained results, we conclude that
although sodium alendronate increased the bone
mineral density and was incorporated to the mineral-
ized dental tissues, there were no significant struc-
tural, morphological, and mechanical alterations in
mature enamel and dentin of rat incisors, suggesting
that the use of alendronate clinically in patients
could be safe.
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